Over 500 companies, including Bharat Petroleum (BPCL) and IRCTC, are set to announce their quarterly earnings on August 13, ...

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

EMERYVILLE, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, reported its 2025 second quarter and year to date financial results and ...

Oric Pharmaceuticals’ previously announced plan to focus resources on its two most advanced oncology drugs comes with a sting in its tail—the therapeutic-resistance-focused biotech is laying off 20 | ...

The firm is touting its AI-driven foundation model's ability to predict how any patient will respond to any drug, allowing sponsors to fine-tune their trials.

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

A new market analysis report reveals the global generic injectable market is poised for explosive growth, with its value ...

The Trump administration has imposed a tariff of 39 percent on Swiss goods — drastically higher than the rates for the EU or ...

Pain management is among the most commonly reportedly reasons for medical cannabis use, but side effects have stymied many ...

You'll recognize the maker of this drug, which treats an issue affecting a larger percentage of the population than many ...

ProPublica identified more than 150 products that were exempted from import bans since 2013. Our list provides the names of ...